{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:36:01Z","timestamp":1791416161158,"version":"4.3.3"},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,10,15]]},"DOI":"10.2169\/internalmedicine.0966-18","type":"journal-article","created":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T18:33:27Z","timestamp":1539542007000},"page":"3021-3024","source":"Crossref","is-referenced-by-count":11,"title":["Late-onset Myasthenia Gravis Accompanied by Amyotrophic Lateral Sclerosis with Antibodies against the Acetylcholine Receptor and Low-density Lipoprotein Receptor-related Protein 4"],"prefix":"10.2169","volume":"57","author":[{"given":"Keiko","family":"Ohnari","sequence":"first","affiliation":[{"name":"Department of Neurology, University of Occupational and Environmental Health School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Occupational and Environmental Health School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, National Hospital Organization Nagasaki Kawatana Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Nagasaki Kawatana Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Adachi","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Occupational and Environmental Health School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 14: 1023-1036, 2015.","DOI":"10.1016\/S1474-4422(15)00145-3"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Higuchi O, Hamuro J, Motomura M, Yamanashi Y. Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis. Ann Neurol 69: 418-422, 2011.","DOI":"10.1002\/ana.22312"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Zisimopoulou P, Evangelakou P, Tzartos J, et al. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis. Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis. J Autoimmun 52: 139-145, 2014.","DOI":"10.1016\/j.jaut.2013.12.004"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Cordts I, Bodart N, Hartmann K, et al. Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis. J Neurol 264: 1193-1203, 2017.","DOI":"10.1007\/s00415-017-8514-z"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ohno K, Ohkawara B, Ito M. Agrin-LRP4-MuSK signaling as a therapeutic target for myasthenia gravis and other neuromuscular disorders. Expert Opin Ther Targets 21: 949-958, 2017.","DOI":"10.1080\/14728222.2017.1369960"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mori S, Motohashi N, Takashima R, Kishi M, Nishimune H, Shigemoto K. Immunization of mice with LRP4 induces myasthenia similar to MuSK-associated myasthenia gravis. Exp Neurol 297: 158-167, 2017.","DOI":"10.1016\/j.expneurol.2017.08.006"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tzartos JS, Zisimopoulou P, Rentzos M, et al. LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients. Ann Clin Transl Neurol 1: 80-87, 2014.","DOI":"10.1002\/acn3.26"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Rivner MH, Liu S, Quarles B, et al. Agrin and low-density lipoprotein-related receptor protein 4 antibodies in amyotrophic lateral sclerosis patients. Muscle Nerve 55: 430-432, 2017.","DOI":"10.1002\/mus.25438"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Del Mar Amador M, Vandenberghe N, Berhoune N, et al. Unusual association of amyotrophic lateral sclerosis and myasthenia gravis: a dysregulation of the adaptive immune system? Neuromuscul Disord 26: 342-346, 2016.","DOI":"10.1016\/j.nmd.2016.03.004"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. de Carvalho M, Dengler R, Eisen A, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 119: 497-503, 2008.","DOI":"10.1016\/j.clinph.2007.09.143"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. de Pasqua S, Cavallieri F, D'Angelo R, et al. Amyotrophic lateral sclerosis and myasthenia gravis: association or chance occurrence? Neurol Sci 38: 441-444, 2017.","DOI":"10.1007\/s10072-016-2787-3"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Turner MR, Goldacre R, Ramagopalan S, Talbot K, Goldacre MJ. Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology 81: 1222-1225, 2013.","DOI":"10.1212\/WNL.0b013e3182a6cc13"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Puentes F, Malaspina A, van Noort JM, Amor S. Non-neuronal cells in ALS: role of glial, immune cells and blood-CNS barriers. Brain Pathol 26: 248-257, 2016.","DOI":"10.1111\/bpa.12352"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lu CH, Allen K, Oei F, et al. Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm 3: e244, 2016.","DOI":"10.1212\/NXI.0000000000000244"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Malaspina A, Puentes F, Amor S. Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective. Int Immunol 27: 117-129, 2015.","DOI":"10.1093\/intimm\/dxu099"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Gilhus NE. Myasthenia gravis. N Engl J Med 376: e25, 2017.","DOI":"10.1056\/NEJMc1701027"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Takahashi H, Noto YI, Makita N, et al. Myasthenic symptoms in anti-low-density lipoprotein receptor-related protein 4 antibody-seropositive amyotrophic lateral sclerosis: two case reports. BMC Neurol 16: 229, 2016.","DOI":"10.1186\/s12883-016-0758-1"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/20\/57_0966-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T00:56:26Z","timestamp":1539996986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/20\/57_0966-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,15]]},"references-count":17,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0966-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,15]]}}}